Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Completed × Ursodeoxycholic Acid × Clear all

Phase

Phase NA 1 Phase 2/3 1 Phase 2 1

Status

Unknown 1 Terminated 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Cyclophosphamide 613 Cisplatin 570 Gemcitabine 540 Bevacizumab 516 Carboplatin 510 Paclitaxel 500 Docetaxel 486 Radiotherapy 470 Fluorouracil 350 Oxaliplatin 332 Rituximab 317 Capecitabine 304 Doxorubicin 302 Filgrastim 276 Etoposide 275 Irinotecan 268 Dexamethasone 261 Leucovorin 241 Cetuximab 223 pembrolizumab 220 Cytarabine 200 Bortezomib 192 Trastuzumab 187 Erlotinib Hydrochloride 185 Prednisone 184 Vincristine 182 Nivolumab 180 Pemetrexed 172 fludarabine phosphate 163 Temozolomide 162

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01149304 2017-11-20

ELDORADO

University of Magdeburg

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡